Earnest Partners LLC boosted its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,196,712 shares of the company’s stock after buying an additional 99,466 shares during the quarter. Earnest Partners LLC’s holdings in Avantor were worth $77,335,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC raised its stake in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor during the 2nd quarter worth approximately $32,000. Osaic Holdings Inc. increased its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in Avantor by 172.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock valued at $46,000 after purchasing an additional 2,346 shares during the last quarter. Finally, Allworth Financial LP raised its position in Avantor by 110.0% in the second quarter. Allworth Financial LP now owns 3,740 shares of the company’s stock valued at $50,000 after purchasing an additional 1,959 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Avantor
In related news, Director Sanjeev K. Mehra purchased 125,000 shares of the company’s stock in a transaction on Tuesday, March 10th. The shares were bought at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the completion of the purchase, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. This trade represents a 35.71% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gregory T. Lucier acquired 50,000 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were bought at an average cost of $9.16 per share, for a total transaction of $458,000.00. Following the acquisition, the director owned 50,000 shares of the company’s stock, valued at $458,000. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 275,000 shares of company stock valued at $2,399,250. Corporate insiders own 1.20% of the company’s stock.
Avantor Stock Performance
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.Avantor’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have commented on the company. Stifel Nicolaus set a $10.00 price target on Avantor in a research note on Thursday, February 12th. Robert W. Baird set a $11.00 price objective on Avantor in a research note on Thursday, February 12th. TD Cowen reiterated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. UBS Group reiterated a “neutral” rating and issued a $10.50 price objective on shares of Avantor in a report on Thursday, February 12th. Finally, Bank of America cut Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price for the company. in a report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $11.80.
Check Out Our Latest Analysis on Avantor
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Recommended Stories
- Five stocks we like better than Avantor
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
